Can Genetic Testing Predict TRT Response? What It Actually Tells You
Not exactly — but the answer matters. The Precision Peptide Genetic Test doesn't predict whether a specific androgen protocol will work. It maps six biological variables that determine how testosterone behaves in your body: SHBG, CYP19A1, AR, SRD5A2, LHCGR, and CYP17A1. Part of 14 pathways and 150+ genetic insights, that map is the most actionable starting point available.
What Is the Reproductive Health Pathway in Genetic Testing?
In the Precision Peptide Genetic Test, the Reproductive Health pathway delivers 6 insights across genes governing testosterone bioavailability, estrogen conversion, androgen receptor sensitivity, DHT production, and HPTA axis function. Part of 14 pathways, 49 peptides, and 150+ genetic insights, these 6 insights map male hormone balance as a connected genetic system.
What Genes Affect Testosterone Levels? The Complete Genetic Guide
The Precision Peptide Genetic Test analyzes six Reproductive Health genes that directly influence testosterone levels, conversion, and signaling — including SHBG, CYP19A1, AR, SRD5A2, LHCGR, and CYP17A1. Part of 14 pathways and 150+ genetic insights across 49 peptides, these variants explain why testosterone behaves differently in different men.
Why TRT Works for Some Men and Not Others: The Genetic Answer
The Precision Peptide Genetic Test analyzes 6 Reproductive Health insights that explain why androgen-pathway protocols produce different outcomes for different men. SHBG, CYP19A1, AR, SRD5A2, LHCGR, and CYP17A1 each shape how testosterone is bound, converted, sensed, and signaled — as part of 14 pathways and 150+ genetic insights across 49 peptides.
HPTA Axis Genetics: LH, FSH, and Fertility Preservation in Men
The Precision Peptide Genetic Test analyzes LH and FSH receptor variants — the genes governing how sensitively your HPTA axis signals testosterone production and sperm health. Part of 14 pathways and 150+ genetic insights across 49 peptides, your HPTA genetics help explain why fertility preservation strategies matter differently for different men on androgen-pathway protocols.